斯達(dá)特(Starter)，國產(chǎn)抗體專家，
產(chǎn)品別名: HBP Recombinant Rabbit mAb (SDT-506-97)

Heparin-binding protein (HBP), also known as Azurocidin and cationic antimicrobial protein 37 (CAP37), is a member of the serine protease family that includes Cathepsin G, neutrophil elastase (NE), and proteinase 3 (PR3). HBP has been recognized as a player in the activation and modulation of the immune response and may act to alarm the immune system. The cationic domain at one side of the protein is essential for its antimicrobial activity. It is stored in azurophil granules as well as secretory granules and as a result partly released at early stage of extravasation. HBP is involved in chemotaxis and activation of monocytes, cytokine release and phagocytosis leading to more efficient bacterial clearance. HBP is a reasonable therapeutic target for a variety of inflammatory disease conditions, and a promising biomarker in predicting development and prognosis of severe sepsis and septic shock.

杭州斯達(dá)特專注于抗體研發(fā)和制造，其核心團(tuán)隊深耕抗體研發(fā)十五年，提供優(yōu)質(zhì)的抗體、蛋白、試劑盒和定制服務(wù)，包括科研抗體、CDx和IVD抗原和抗體原料、一步法ELISA試劑盒、鼠兔通用二抗試劑盒以及其他用途的免疫試劑整體解決方案。公司建立了多物種單B細(xì)胞抗體開發(fā)平臺（兔單抗，鼠類單抗等）、傳統(tǒng)鼠單抗、重組蛋白表達(dá)平臺及完善的抗體應(yīng)用驗證和檢測體系（包括免疫層析，酶聯(lián)免疫，流式分析，免疫組化，免疫印跡，免疫熒光，免疫沉淀等）。已正式通過歐盟98/79/EC認(rèn)證、ISO9001認(rèn)證和ISO13485認(rèn)證。 官網(wǎng)點擊查詢：www.starter-bio.com